Radboudumc

Public research footprint of Radboudumc, compiled from the ClinicalTrials.gov public registry.

472

Registered studies

181

Active

105

Recruiting now

170

Completed

Stopped or withdrawn

Most-studied conditions

Non-small Cell Lung Cancer · Endometrial Cancer · Ulcerative Colitis · Relapsed or Refractory Multiple Myeloma (RRMM)

Recently updated registry entries

NCT07463183 — A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to… (Recruiting)
NCT05347095 — A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease (Active Not Recruiting)
NCT07513376 — A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Radboudumc?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.